56R-27387-96784
2 vaccinations
2 coded responses
13 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 926 / CA
- Registered
- 2021-01-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Dose 1 — Pfizer-BioNTech
-
2021-01-24
Registered in v-safe
- 2021-01-26
- 2021-01-27
- 2021-01-29
- 2021-02-06
-
2021-02-13
Dose 2 — Pfizer-BioNTech
- 2021-02-20
-
2021-02-27
Survey response — day 14, dose 2MedDRA: Rhinorrhoea, Sneezing — Feeling: FairFree text: Sneezing runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — day 21, dose 2MedDRA: Headache — Feeling: GoodFree text: Head acheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
- 2021-03-22
- 2021-03-29
- 2021-05-15
- 2021-08-16
- 2022-02-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-13 | Pfizer-BioNTech |
Free text
Release 4 — day 14, dose 2
Symptoms: Sneezing runny nose
Release 5 — day 21, dose 2
Symptoms: Head ache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release